21.482 articles found

Treatment with AC pulsed electromagnetic fields improves olfactory function in Parkinson's disease.

Sandyk R.

Int J Neurosci · 1999-04-01

DOI: 10.3109/00207459909000662PMID: 10372649

Parkinson's disease. Drug treatment in old age.

Derbyshire M, Marsden V.

Elder Care · 1999-04-01

DOI: 10.7748/eldc.11.2.31.s28PMID: 10542523

Membrane-bound receptors and their function cognitive disfunction treatments therefor and compositions for use in such treatments

XIA ZONGQIN, BROSTOFF JONATHAN, WHITTLE BRIAN, UBIN IAN, HU YAER, WANG WEIJUN, GUNNING PHIL.

· 1999-03-26

Worsening of levodopa-induced dyskinesias by motor and mental tasks.

Durif F, Vidailhet M, Debilly B, Agid Y.

Mov Disord · 1999-03-01

DOI: 10.1002/1531-8257(199903)14:2<242::aid-mds1007>3.0.co;2-wPMID: 10091616

Apomorphine and levodopa challenge in patients with a focal midbrain lesion.

Moro E, Albanese A.

Mov Disord · 1999-03-01

DOI: 10.1002/1531-8257(199903)14:2<269::aid-mds1012>3.0.co;2-xPMID: 10091621

Restorative gene therapy approaches to Parkinson's disease.

Freese A.

Med Clin North Am · 1999-03-01

DOI: 10.1016/s0025-7125(05)70119-xPMID: 10093593

Pharmacodynamic modelling of levodopa, 3-O-methyldopa and their effects: an application of the Dixon equation.

Wu G, Furlanut M.

Pharmacol Res · 1999-03-01

DOI: 10.1006/phrs.1998.0435PMID: 10094845

Classification of tremor and update on treatment.

Charles PD, Esper GJ, Davis TL, Maciunas RJ, Robertson D.

Am Fam Physician · 1999-03-01

PMID: 10193597

Controlled release levodopa in Parkinson's disease: influence of selection criteria and conversion recommendations in the clinical outcome of 450 patients. STAR Study Group.

Linazasoro G, Grandas F, Martínez Martín P, Bravo JL.

Clin Neuropharmacol · 1999-03-01

DOI: 10.1097/00002826-199903000-00002PMID: 10202601

High-dose methamphetamine treatment alters presynaptic GABA and glutamate immunoreactivity.

Burrows KB, Meshul CK.

Neuroscience · 1999-03-01

DOI: 10.1016/s0306-4522(98)00506-5PMID: 10218784

[Treating Parkinson-patients with dopamine agonists. Role of the age at manifestation in the therapy].

Check source for author details

Nervenarzt · 1999-03-01

PMID: 10221136

[Entacapone++ : a new catechol-O-methyltransferase inhibitor which improves the response to levodopa in patients with Parkinson disease and fluctuating motor function].

Horga de la Parte JF.

Rev Neurol · 1999-03-01

DOI: 10.33588/rn.2805.99104PMID: 10229966